Inventor · disambiguated record
David Tumelty
Also filed as: TUMELTY DAVID
11 granted patents·12 pending applications·247 citations·filing 2004–2023
89Inventor score
Files withAFFYMAX INC10HOLMES CHRISTOPHER P5VASOMUNE THERAPEUTICS INC3BHAT ABHIJIT SURESH1BRADSHAW CURT W1
Top patents by PatentIndex Score
23 records- 0197US7084245B2Peptides that bind to the erythropoietin receptorAFFYMAX INC·Filed 2004·Granted Aug 1, 2006·181 cites·72 claims
- 0287US8741291B2Multifunctional antibody conjugatesBHAT ABHIJIT SURESH·Filed 2011·Granted Jun 3, 2014·37 cites·42 claims
- 0385US7414105B2Peptides that bind to the erythropoietin receptorAFFYMAX INC·Filed 2005·Granted Aug 19, 2008·6 cites·13 claims
- 0484US7528104B2Peptides that bind to the erythropoietin receptorAFFYMAX INC·Filed 2004·Granted May 5, 2009·15 cites·47 claims
- 0581US7855175B2Peptides that bind to the erythropoietin receptorAFFYMAX INC·Filed 2008·Granted Dec 21, 2010·3 cites·12 claims
- 0677US8304391B2Peptides that bind to the erythropoietin receptorHOLMES CHRISTOPHER P·Filed 2009·Granted Nov 6, 2012·2 cites·29 claims
- 0774US11384130B2Agent for promoting angiogenesis and methods and uses thereofVASOMUNE THERAPEUTICS INC·Filed 2018·Granted Jul 12, 2022·1 cites·26 claims
- 0872US7919118B2Spacer moiety for poly (ethylene glycol) modified peptide based compoundsAFFYMAX INC·Filed 2004·Granted Apr 5, 2011·1 cites·44 claims
- 0970US8729030B2Peptides that bind to the erythropoietin receptorHOLMES CHRISTOPHER P·Filed 2010·Granted May 20, 2014·1 cites·22 claims
- 1062US2022372095A1An agent for promoting angiogenesis and methods and uses thereofVASOMUNE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1159US2024083962A1Agent for promoting angiogenesis and methods and uses thereofVASOMUNE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1257US2008108564A1Novel peptides that bind to the erythropoietin receptorAFFYMAX INC·Filed 2007·Application pending·0 cites
- 1357US2013244939A1Novel peptides that bind to the erythropoietin receptorAFFYMAX INC·Filed 2012·Application pending·0 cites
- 1457US2013130979A1Peptides that bind to the erythropoietin receptorAFFYMAX INC·Filed 2012·Application pending·0 cites
- 1556US11780935B2Mutant antibodies and conjugation thereofPFIZER HEALTHCARE IRELAND·Filed 2020·Granted Oct 10, 2023·0 cites·16 claims
- 1655US2005107297A1Novel poly(ethylene glycol) modified compounds and uses thereofFiled 2004·Application pending·0 cites
- 1752US2013012685A1Novel peptides that bind to the erythropoietin receptorAFFYMAX INC·Filed 2012·Application pending·0 cites
- 1852US2013323234A1Mutant antibodies and conjugation thereofCOVX TECHNOLOGIES IRELAND LTD·Filed 2013·Application pending·0 cites
- 1951US8592365B2Spacer moiety for poly(ethylene glycol) modified peptide based compoundsHOLMES CHRISTOPHER P·Filed 2011·Granted Nov 26, 2013·0 cites·10 claims
- 2050US2011282029A1Novel peptides that bind to the erythropoietin receptorHOLMES CHRISTOPHER P·Filed 2010·Application pending·0 cites
- 2149US2009005292A1Novel Peptides that Bind to the Erythropoietin ReceptorAFFYMAX INC·Filed 2005·Application pending·0 cites
- 2246US2009098130A1Glucagon-like protein-1 receptor (glp-1r) agonist compoundsBRADSHAW CURT W·Filed 2008·Application pending·0 cites
- 2341US2012157660A1Novel peptides that bind to the erythropoietin receptorHOLMES CHRISTOPHER P·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Tumelty files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →